Keyphrases
Measles Virus
100%
Oncolytic Measles Virus
60%
Clinical Trials
55%
Tumor
55%
Phase II Trial
51%
Glioblastoma
49%
Cancer Treatment
45%
Treatment Group
38%
North Central
37%
Virus Strains
36%
Glioma
35%
Antitumor Activity
32%
Neuro-oncology
29%
NCCTG
25%
Meningioma
24%
Brain Tumor
23%
Glioblastoma multiforme
23%
Virotherapy
23%
Virus
22%
Newly Diagnosed Glioblastoma
21%
Recurrent Glioblastoma
20%
Chemotherapy
20%
Carcinoembryonic Antigen
19%
Temozolomide
18%
Bevacizumab
18%
Radiation Therapy
17%
Overall Survival
17%
Aurora A
17%
Ovarian Cancer
16%
Oncolytic
16%
Xenograft
16%
Vaccine Strain
15%
Group Studies
15%
Progression-free Survival
14%
Central Nervous System Tumors
14%
Measles
14%
Brain Metastases
13%
High-grade Glioma
13%
Response Assessment in Neuro-Oncology Criteria
13%
Response Assessment
13%
Phase I Trial
13%
Neutrophil-activating Protein
13%
Breast Cancer
12%
Phase II Study
12%
Oncolytic Virotherapy
12%
Human Sodium Iodide Symporter (hNIS)
12%
Oncolytic Virus
12%
Gene Therapy
11%
Medulloblastoma
11%
Genetic Engineering
11%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
93%
Malignant Neoplasm
83%
Neoplasm
83%
Measles Virus
82%
Clinical Trial
53%
Treatment Group
37%
Virotherapy
30%
Virus Strain
28%
Phase II Trials
25%
Antitumor Activity
24%
Overall Survival
24%
Chemotherapy
22%
Diseases
21%
Intracranial Tumor
21%
Carcinoembryonic Antigen
21%
Temozolomide
20%
Measles
18%
Ovary Cancer
17%
Gene Delivery
15%
Breast Cancer
15%
Bevacizumab
15%
Meningioma
14%
Progression Free Survival
14%
Immunotherapy
13%
Astrocytoma
13%
Sodium Iodide Symporter
11%
Infection
11%
Vorinostat
11%
Vaccine Strain
11%
Combination Therapy
10%
Lontucirev
10%
Irinotecan
10%
Phase I Trials
10%
Aurora A Kinase
10%
Pharmacokinetics
9%
Chemoradiation Therapy
9%
Oligodendroglioma
8%
Adverse Event
8%
Everolimus
8%
Viral Vector
7%
Recurrent Disease
7%
Solid Malignant Neoplasm
7%
Connective Tissue Cancer
7%
Biological Marker
7%
Helicobacter Pylori
7%
Anticonvulsive Agent
7%
Adenoviridae
7%
Heat Shock Protein
7%
Temsirolimus
7%
Interleukin 2
7%
Medicine and Dentistry
Neoplasm
72%
Glioblastoma
67%
Clinical Trial
62%
Measles Virus
51%
Ganglioglioma
37%
Intracranial Tumor
35%
Neuro-Oncology
31%
Malignant Neoplasm
27%
Cancer Therapy
23%
Radiation Therapy
21%
Overall Survival
20%
Xenograft
19%
Oncology
19%
Breast Cancer
18%
Treatment Group
18%
Cancer Cell
18%
Phase II Trials
17%
Diseases
16%
Ovarian Cancer
16%
Antineoplastic Activity
15%
Immunotherapy
14%
Meningioma
14%
Metastatic Carcinoma
14%
Temozolomide
14%
Cancer
13%
Virus
13%
Virotherapy
13%
Recurrent Disease
12%
Virus Strain
12%
Brain Metastasis
12%
Osteosarcoma
11%
Vorinostat
10%
Aurora A Kinase
10%
Carcinoembryonic Antigen
10%
Lontucirev
10%
Carcinogenesis
10%
Magnetic Resonance Imaging
10%
Connective Tissue Cancer
10%
Arm
10%
Measles
9%
Quality of Life
9%
Whole Brain Radiotherapy
9%
Oncolytic Virotherapy
9%
Distant Metastasis
9%
Oligoastrocytoma
9%
Central Nervous System Tumor
9%
Infection
9%
Progression Free Survival
8%
Central Nervous System
8%
Bevacizumab
8%